Kincell is a technology-forward contract development and manufacturing organization (CDMO) that streamlines analytical development, process development, CMC consulting, and early-stage GMP cell therapy manufacturing.
The company develops and manufactures immune cell therapies, including autologous and allogeneic CAR-T, CAR-NK, and CAR-M programs.
